Logo
x

Search

Subscribe Now

marketing

NightWare Receives the US FDA's Approval for the First Medical Device to Stop NightMAres Related to PTSD

NightWare Receives the US FDA's Approval for the First Medical Device to Stop NightMAres Related to PTSD

  • November 11, 2020
Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

Medicure Signs Agreement with Reliance Life Sciences for Marketing Rights of a Cardiovascular Biosimilar

  • October 5, 2020
Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan

Sun Pharma Reports Submission of Manufacturing and Marketing Authorization Application of Tildrakizumab in Japan

  • August 1, 2019
Sanofi Reports Results of Cablivi (caplacizumab) in P-III HERCULES Study in Patients with Rare Blood Clotting Disorder- Published in NEJM

Sanofi Reports Results of Cablivi (caplacizumab) in P-III HERCULES Study in Patients with Rare Blood Clotting Disorder- Published...

  • January 10, 2019
Pharmacosmos' Monoferric 1000 mg IV Receives Health Canada Marketing Approval

Pharmacosmos' Monoferric 1000 mg IV Receives Health Canada Marketing Approval

  • September 7, 2018
Celltrion's Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia

Celltrion's Herzuma (Herceptin biosimilar) Receives Marketing Approval in Australia

  • August 3, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.